Neurocrine Biosciences, Inc. (NBIX) Stock Forecast & Predictions

Neurocrine Biosciences, Inc. NBIX: $96.51

12780 El Camino Real, San Diego, California, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: http://www.neurocrine.com/

  • Market Cap$9.17B
  • Change (52 Weeks)2.82%
  • Low (52 Weeks)$86.02
  • Neurocrine Biosciences, Inc. (NBIX) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 0.00% are on Buy, 50.00% on Sell, and 50.00% Neutral.

    According to the market data, Neurocrine Biosciences, Inc. (NBIX) stock price is $96.51 and the 52 weeks low is $86.02, which means the Neurocrine Biosciences, Inc. stock price is up 2.82% in the last 12 months.

    Neurocrine Biosciences, Inc. (NBIX) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 0.00% are indicating that NBIX Stock price might rise further, 50.00% indicating that NBIX Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall NBIX stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Neurocrine Biosciences, Inc. (NBIX) Stock Forecast By Analysts


    Moderate Buy
    Analysts Recommendations for Neurocrine Biosciences, Inc. (NBIX) is based on 32 Institutional Analyst Ratings where 34.38% are on Strong Buy, 34.38% on Moderate Buy, 31.25% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 32 Institutional Analysts, majority recommended NBIX stock as Moderate Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Neurocrine Biosciences, Inc..

    Neurocrine Biosciences, Inc. (NBIX) Stock Price Prediction By Analysts


    HighLowAverage
    $171.15$102.01$129.39
    $129.3934.07% Upside
    Updated: 2021-04-22 00:00:00

    The Average Price target for NBIX set by the institutional analysts is $129.39 where High Estimate is $171.15, Median $130.56 and Low $102.01.

    The average price target for NBIX by Institutional Analysts is $129.39, which is 34.07% Upside from the current price. So according to the Institutional Analysts, NBIX Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Neurocrine Biosciences, Inc. (NBIX) Stock Forecast Based on News Sentiment


    Neutral
    Based on 1 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of NBIX consisting of positive and negative, it shows that Neurocrine Biosciences, Inc. had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so NBIX stock price most likey won't have any reaction to last weeks news coverage.

    Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    Morgan StanleyOverweightMaintained
    WedbushOutperformMaintained
    MizuhoNeutralMaintained
    Raymond JamesOutperformInitiated
    Morgan StanleyOverweightMaintained
    Canaccord GenuityBuyMaintained
    SVB LeerinkMarket PerformMaintained
    Credit SuisseNeutralMaintained
    BenchmarkHoldInitiated
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyOverweightMaintained
    MizuhoNeutralMaintained
    JP MorganNeutralDowngraded
    HC Wainwright & Co.BuyMaintained
    Credit SuisseNeutralMaintained
    Cantor FitzgeraldOverweightMaintained
    Canaccord GenuityBuyMaintained
    MizuhoNeutralMaintained
    Credit SuisseNeutralMaintained
    Morgan StanleyOverweightMaintained
    Goldman SachsNeutralDowngraded
    JP MorganOverweightMaintained
    HC Wainwright & Co.BuyMaintained
    Canaccord GenuityBuyMaintained
    WedbushOutperformInitiated
    Morgan StanleyOverweightMaintained
    MizuhoNeutralMaintained
    Canaccord GenuityBuyMaintained
    BarclaysEqual-WeightMaintained
    OppenheimerOutperformMaintained
    CitigroupBuyInitiated
    William BlairOutperformInitiated
    MizuhoNeutralInitiated
    H.C. WainwrightBuyReiterated
    Morgan StanleyOverweightMaintained
    OppenheimerOutperformMaintained
    Morgan StanleyOverweightMaintained
    Credit SuisseNeutralDowngraded
    Canaccord GenuityBuyMaintained
    RBC CapitalOutperformInitiated
    Piper JaffrayOverweightMaintained
    Credit SuisseOutperformMaintained
    GuggenheimNeutralInitiated
    Credit SuisseOutperformInitiated
    JP MorganOverweightUpgraded
    Evercore ISI GroupOutperformInitiated
    NeedhamHoldDowngraded
    JP MorganNeutralDowngraded
    Goldman SachsBuyInitiated
    Canaccord GenuityBuyInitiated
    Leerink SwannMarket PerformInitiated
    Morgan StanleyOverweightMaintained
    Stifel NicolausBuyMaintained
    Morgan StanleyOverweightInitiated
    Cantor FitzgeraldOverweightInitiated
    Stifel NicolausBuyInitiated
    BarclaysOverweightMaintained
    BairdOutperformMaintained
    JP MorganOverweightMaintained
    Deutsche BankBuyMaintained
    Bank of AmericaBuyMaintained
    BairdOutperformMaintained
    JP MorganOverweightMaintained
    OppenheimerOutperformMaintained
    Leerink SwannOutperformMaintained
    BMO CapitalOutperformMaintained
    BarclaysOverweightMaintained
    JefferiesBuyMaintained
    Bank of AmericaBuyInitiated
    OppenheimerOutperformUpgraded
    OppenheimerPerformInitiated
    Deutsche BankBuyInitiated
    NeedhamBuyInitiated
    H.C. WainwrightBuyInitiated
    BMO CapitalOutperformInitiated
    JP MorganOverweightMaintained
    PiperJaffrayOverweightMaintained
    JP MorganOverweightInitiated
    BarclaysOverweightInitiated
    Deutsche BankBuyMaintained
    JefferiesBuyMaintained
    JefferiesBuyMaintained
    Deutsche BankBuyMaintained
    Deutsche BankBuyMaintained
    JefferiesBuyMaintained
    MKM PartnersBuyMaintained
    JefferiesBuyMaintained
    NomuraBuyInitiated
    Morgan StanleyEqual-weightDowngraded
    Deutsche BankBuyMaintained
    PiperJaffrayOverweightInitiated
    Deutsche BankBuyMaintained
    Cowen & Co.OutperformUpgraded
    OppenheimerOutperformInitiated
    JefferiesBuyMaintained
    LazardBuyInitiated
    Morgan StanleyOverweightInitiated
    Deutsche BankBuyInitiated

    Neurocrine Biosciences, Inc. (NBIX) Stock Earning Per Share (EPS) Forecast / Estimate


    $0.708
    The average consensus EPS for NBIX is $0.708 with a high estimate of $1.008 and Low of $0.255 for the period 2021-06-30 and based on 26 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-0.62$0.173879400000000022020-09-30


    The latest average Earning Per Share Estimate for Neurocrine Biosciences, Inc. is $0.71, which is higher than NBIX's last EPS, $-0.62. This means that Analysts are expecting Neurocrine Biosciences, Inc. to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Neurocrine Biosciences, Inc..

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-0.62$0.173879400000000022020-09-30
    $0.81$0.74943482020-06-30
    $0.39$0.55167722020-03-31
    $0.35$0.76595882019-12-31
    $0.56$0.65102520000000012019-09-30
    $0.54$0.10884422019-06-30
    $-1.12$-0.94313282019-03-31
    $0.19$0.18632342018-12-31
    $0.52$0.466652018-09-30
    $-0.07$-0.171135600000000032018-06-30
    $-0.47$-0.309062018-03-31
    $0.07$0.18517082017-12-31
    $-0.13$-0.49044662017-09-30
    $-0.68$-0.675752017-06-30
    $-0.9$-0.75054662017-03-31
    $-0.51$-0.57545342016-12-31
    $-0.43$-0.579362016-09-30
    $-0.46$-0.50319662016-06-30
    $-0.22$-0.290699999999999962016-03-31
    $-0.34$-0.32785862015-12-31
    $-0.4$-0.257552015-09-30
    $-0.28$-0.2919752015-06-30
    $-0.01$-0.3062015-03-31
    $-0.26$-0.24819662014-12-31
    $-0.21$-0.21422014-09-30
    $-0.18$-0.18530342014-06-30
    $-0.17$-0.197625000000000022014-03-31
    $-0.16$-0.176796600000000032013-12-31
    $-0.17$-0.206552013-09-30
    $-0.18$-0.197625000000000022013-06-30
    $-0.18$-0.1823252013-03-31
    $0.14$-0.080325000000000012012-12-31
    $-0.05$-0.05391722012-09-30
    $-0.01$-0.02889662012-06-30
    $-0.01$-0.00680342012-03-31
    $0.02$0.01532011-12-31
    $0.56$0.19382011-09-30
    $0.04$0.065282011-06-30
    $0.05$0.05439662011-03-31
    $0.04$0.03909662010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).